InterMune Inc. (ITMN)
Loading...
Symbols:
ITMN Forum Topics
loading ...Recent ITMN Articles
- Friday Options Outlook: GFI, GDX, FRX, BP, CPN, ITMN, S
- Pharma, Biotech Present Great Investment Opportunities in 2008
- Screening for Potential Buyout Targets
- Biotech Stocks: InterMune Retrenches
-
Biotech Day In Review: InterMune Scaling Back Operations, MGI's Positive Trial
on Mar 21, 2007| by
- Biotech Day in Review: Novartis Gets Approval for Hypertensive Drug Tekturna
- Biotech Stocks Review: Amphora Sells Oncology Program to Genentech
- Investors Infected With Vertex Fever Should Seek Healthier Stocks -- Barron's
- Full List of Articles »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Editors
General Discussion on ITMN
Is this a buy or a sell? ReplyPharma, Biotech Present Great Investment Opportunities in 2008 [view article]
The hidden jewel is Synta Pharm (SNTA). Only GSK has noticed.... ReplyPharma, Biotech Present Great Investment Opportunities in 2008 [view article]
Have anyone checked out oxigene? CEO Richard Chin have stated they will have a partner within next 6 months! It will be a deal close to what Antisoma got last year 890 milj$ or better. Check out oxigens market cap and do the math. It is a 10 bagger!Good Luck! Reply
Screening for Potential Buyout Targets [view article]
I'm with you James, this one shouldn't have passed the debt to equity screen. As an anecdotal story, I used to work for a bank that paid over $100,000 per month for one of the most respected quant models in the industry. After several months, it was discovered that one of the factors in the model (9 month earnings momentum) was completely wrong! That's why I never rely totally on quant models and stocks screens. They're just a starting point, and should be re-tested regularly and followed up with detailed fundamental analysis. Thanks for bringing this to our attention! ReplyScreening for Potential Buyout Targets [view article]
Curious as to how a copany like HLS would pass the debt to equity screen. It has no equity. ReplyScreening for Potential Buyout Targets [view article]
Ralph- This is an art more than a science (I build a screen like this every couple months and I use slightly different factors every time). The goal is to figure out which companies will be the next takeover targets before there is actually any public information. If you want concrete numbers, try market capitalization between $500 million and $8 billion (this seems to be the sweet spot for a lot of buyouts), debt to equity less than 0.5 (in reality the lower the better), and positive cash flow consisting mostly of cash flow from operations (again, the more the better). Once you’ve got your list, try to think like a private equity firm. If you wanted to make a ton of money, which firm would you acquire? If you want more concrete numbers, check out CNBC’s 13 factor takeover target profile: (www.portfoliochallenge...).Mark Hines Reply
Screening for Potential Buyout Targets [view article]
It would be helpful to know exactly what factors you used to generate this screen. Can you be more specific than "companies with small or mid market capitalizations (large caps are often too big to be bought out), low debt ratios (so the acquirer can add more debt to pay for the aquisition), high cash flows (to pay down the new debt), and a variety of management issues (room for improvement)"? Reply